- Home
- CJJD vs AYTU Comparison
CJJD vs AYTU Comparison
Compare CJJD & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJJD
- AYTU
- Stock Information
- Founded
- CJJD 2003
- AYTU N/A
- Country
- CJJD China
- AYTU United States
- Employees
- CJJD N/A
- AYTU N/A
- Industry
- CJJD Retail-Drug Stores and Proprietary Stores
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- CJJD Consumer Staples
- AYTU Health Care
- Exchange
- CJJD Nasdaq
- AYTU Nasdaq
- Market Cap
- CJJD 11.2M
- AYTU 10.5M
- IPO Year
- CJJD N/A
- AYTU N/A
- Fundamental
- Price
- CJJD $1.75
- AYTU $1.72
- Analyst Decision
- CJJD
- AYTU
- Analyst Count
- CJJD 0
- AYTU 0
- Target Price
- CJJD N/A
- AYTU N/A
- AVG Volume (30 Days)
- CJJD 17.4K
- AYTU 27.8K
- Earning Date
- CJJD 07-30-2024
- AYTU 02-12-2025
- Dividend Yield
- CJJD N/A
- AYTU N/A
- EPS Growth
- CJJD N/A
- AYTU N/A
- EPS
- CJJD N/A
- AYTU N/A
- Revenue
- CJJD $147,126,392.00
- AYTU $79,759,000.00
- Revenue This Year
- CJJD N/A
- AYTU N/A
- Revenue Next Year
- CJJD N/A
- AYTU N/A
- P/E Ratio
- CJJD N/A
- AYTU N/A
- Revenue Growth
- CJJD 3.85
- AYTU N/A
- 52 Week Low
- CJJD $1.34
- AYTU $1.30
- 52 Week High
- CJJD $4.80
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- CJJD 42.25
- AYTU 54.14
- Support Level
- CJJD $1.87
- AYTU $1.60
- Resistance Level
- CJJD $1.97
- AYTU $1.93
- Average True Range (ATR)
- CJJD 0.19
- AYTU 0.13
- MACD
- CJJD -0.00
- AYTU 0.01
- Stochastic Oscillator
- CJJD 16.55
- AYTU 57.00
About CJJD China Jo-Jo Drugstores Inc. (Cayman Islands)
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.